70 reports

  • 6.1 INTRODUCTION
  • FUNCTIONAL FOOD INGREDIENTS MARKET SIZE, BY TYPE, 2016-2023 (USD MILLION)

PREBIOTICS RESIST GASTRIC ACIDITY AND HYDROLYSIS CAUSED BY ENZYMES AND GASTROINTESTINAL ABSORPTION.

  • Mineral Supplement
  • United States
  • Market Size
  • Arla Foods
  • Cargill Inc.

One of the major reasons for the high bioavailability of organic minerals is that, unlike inorganic minerals, these do not interact with fiber, tannin, phytate, silicates, oxalate, or other minerals in the gastrointestinal tract.

  • Mineral Supplement
  • Pig
  • World
  • Alltech Inc.
  • Kemin Industries, Inc.
  • 8.2 NOVARTIS

Oral ibuprofen at high doses can induce gastrointestinal bleeding and kidney complications when combined with the antibiotics that cystic fibrosis patients also need.

  • Genetic Disorder
  • Mineral Supplement
  • World
  • Market Size
  • AbbVie Inc.

THE MICROPEARLS SPRAY FREEZING TECHNOLOGY ALLOWS FOR THE TIMELY RELEASE OF THESE ## KEY NUTRIENTS THROUGHOUT AN ANIMAL' S GASTROINTESTINAL TRACT.

  • Mineral Supplement
  • North America
  • United States
  • World
  • Market Size

MARKET ##.

  • Mineral Supplement
  • APAC
  • Japan
  • World
  • Demand
  • VITAMIN & MINERAL PREMIXES MARKET, BY FUNCTIONALITY

Q. ##.

  • Genetic Disorder
  • Mineral Supplement
  • Market Size
  • Glanbia plc
  • Nutreco N.V.
  • U.K. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET, BY TYPE
  • TRANSDERMAL DRUG DELIVERY SYSTEM MARKET DRIVER

About one in four men and nearly one in five women age ## to ## has high blood pressure.

  • Genetic Disorder
  • Transdermal Delivery
  • North America
  • World
  • Boehringer Ingelheim GmbH
  • GENETIC DISORDERS MARKET, GLOBAL, OVERALL PHARMACEUTICAL INDUSTRY PIPELINE BY
  • GENETIC DISORDERS MARKET, GLOBAL, ANNUAL REVENUE FOR VIMIZIM ($BN), 2014-2023

Additionally, as CF is a multi-system disease pancreatic, gastrointestinal and reproductive problems will remain even if the lung transplant is successful.

  • Genetic Disorder
  • Mineral Supplement
  • World
  • Market Size
  • Alexion Pharmaceuticals, Inc.

You can easily book an appointment with one online.

  • Mineral Supplement
  • World
  • Market Size
  • Alltech Inc.
  • Kemin Industries, Inc.

DURING CHILDHOOD, ASTHMA IS MORE COMMON IN MALES, WITH A MALE-TO-FEMALE RATIO OF ##:## UP TO PUBERTY, WHEN IT CHANGES TO ##:##.

  • Genetic Disorder
  • Mineral Supplement
  • World
  • Market Size
  • Astellas Pharma Inc.

Global Cystic Fibrosis Therapeutics Market 2016-2026 ##.

  • Cystic Fibrosis
  • Genetic Disorder
  • United States
  • World
  • Forecast

Dietary fibers can act by changing the nature of the contents of the gastrointestinal tract and by changing how other nutrients and chemicals are absorbed.

  • Mineral Supplement
  • China
  • Demand
  • Amway Corporation
  • Joincare Pharmaceutical Group Industry Co., Ltd.
  • 4.3.1 ELECTROPORATION ABLATION TECHNOLOGY

The company recently completed its first clinical study in humans for the removal of pre-cancerous cells in the gastrointestinal tract.

  • Genetic Disorder
  • Mineral Supplement
  • Transdermal Delivery
  • World
  • Market Size
  • SUMMARIZES THE SYMPTOMS OF CF.
  • 11.1 BIBLIOGRAPHY

CF MAINLY AFFECTS THE RESPIRATORY AND GASTROINTESTINAL TRACTS.

  • Genetic Disorder
  • Mineral Supplement
  • Novartis AG
  • Pharmaxis Ltd
  • Vertex Pharmaceuticals Incorporated

Dietary fibers can act by changing the nature of the contents of the gastrointestinal tract and by changing how other nutrients and chemicals are absorbed.

  • Energy
  • Mineral Supplement
  • Vitamin
  • China
  • Demand

You can easily book an appointment with one online.

  • Genetic Disorder
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Novartis AG

It is estimated that worldwide one in five men and one in three women are at risk of an osteoporotic fracture.

  • Mineral Supplement
  • World
  • Forecast
  • Quidel Corporation
  • Roche Group

The subsidiary is focused on aging care, critical care & surgery, gastrointestinal function, and pediatrics.

  • Mineral Supplement
  • North America
  • United States
  • Demand
  • Market Size
  • INTRODUCTION

THE ORGANS THAT ARE TYPICALLY AFFECTED BY CYSTIC FIBROSIS INCLUDE THE LUNGS, THE GASTROINTESTINAL TRACT, THE RESPIRATORY TRACT, THE PANCREAS AND THE LIVER.

  • Genetic Disorder
  • North America
  • United States
  • AstraZeneca PLC
  • Novartis AG

Q. ##.

  • Meat
  • Mineral Supplement
  • Transdermal Delivery
  • Cargill Inc.
  • Koninklijke DSM N.V.
  • BIOTECHNOLOGICAL ISSUES
  • OTHER DRUG DELIVERY SYSTEMS

By avoiding the gastrointestinal system, the drug is less likely to cause nausea.

  • Genetic Disorder
  • Transdermal Delivery
  • Generex Biotechnology Corporation
  • Nitto Denko Corporation
  • Noven Pharmaceuticals, Inc.

The prominent features of this report are - ##.

  • Genetic Disorder
  • World
  • Baxter International Inc.
  • Biotest AG
  • CSL Limited
  • CYSTIC FIBROSIS - PIPELINE BY SEQUOIA SCIENCES INC, H2 2018
  • Indication Name

Of particular note was the absence of gastrointestinal symptoms related to administration of the drug.

  • Genetic Disorder
  • Mineral Supplement
  • United States
  • Company
  • Galapagos NV

The current products for IPF have generated global revenues in excess of $## billion in 2016.

  • Genetic Disorder
  • Pharmaceutical
  • Australia
  • Company
  • Pharmaxis Ltd

The increased loss in the quarter and twelve-month period ended December ##, 2016, compared to the prior year, was the result of increased clinical trial costs related to two Phase ## studies and one Phase ## study conducted during 2016, compared with only a single Phase ##b study and

  • Genetic Disorder
  • United States
  • Company
  • M&A
  • Nivalis Therapeutics, Inc.

The company reported one pharmaceuticals & healthcare deal each in 2016 and 2017.

  • Genetic Disorder
  • United States
  • Company Financials
  • M&A
  • RP Management LLC

Transdermal Patch Market & Pipeline Insight 2015 ##.

  • Drug Delivery
  • Pharmaceutical
  • Transdermal Delivery
  • World
  • Clinical Trial profile. 65 Trial Title
  • CLINICAL TRIAL PROFILE SNAPSHOTS

Urea Cycle Disorders Global Clinical Trials Review, H2, 2018 Summary GlobalData’s clinical trial report, “Urea Cycle Disorders Global Clinical Trials Review, H2, 2018" provides an overview of Urea Cycle Disorders clinical trials scenario.This report provides top line data relating to the clinical...

  • Genetic Disorder
  • Therapy
  • World
  • Product Initiative
  • Horizon Pharma plc
  • 5.2 MARKET DYNAMICS

Lavipharm offers pharmaceutical products for cardiology, chronic pain & oncology, central nervous system, general medicine, gastrointestinal system, and urology.

  • Transdermal Delivery
  • North America
  • United States
  • Forecast
  • Luye Pharma Group Ltd.
  • SMART PATCH IONTOPHORETIC DRUG DELIVERY - PRODUCT DESCRIPTION
  • IRON SUPPLEMENT PATCH - PRODUCT DESCRIPTION

Transdermal Drug Delivery - Medical Devices Pipeline Assessment, 2018 Summary GlobalData’s Medical Devices sector report, “Transdermal Drug Delivery - Medical Devices Pipeline Assessment, 2018" provides an overview of Transdermal Drug Delivery currently in pipeline stage. The report provides...

  • Genetic Disorder
  • Mineral Supplement
  • Pharmaceutical
  • Transdermal Delivery
  • United States